{
    "clinical_study": {
        "@rank": "105917", 
        "acronym": "DARTS", 
        "arm_group": [
            {
                "arm_group_label": "Anxiety Risk Reduction", 
                "arm_group_type": "Experimental", 
                "description": "The anxiety risk reduction condition will be a combination of psychoeducation plus Cognitive Bias Modification (CBM-I) for anxiety sensitivity (AS). The psychoeducational component will focus on the nature of stress and its effect on the body. Interoceptive exposure (IE) exercises, designed to correct the conditioned fear to these bodily sensations, will be explained and practiced."
            }, 
            {
                "arm_group_label": "Mood Risk Reduction", 
                "arm_group_type": "Experimental", 
                "description": "The mood risk reduction condition will be a combination of psychoeducation plus Cognitive Bias Modification (CBM-I) for perceived burdensomeness and thwarted belongingness. The psychoeducational component will focus on dispelling myths related to burdensomeness and belongingness and describe their role in the development of mood symptoms."
            }, 
            {
                "arm_group_label": "Combined Risk Reduction", 
                "arm_group_type": "Experimental", 
                "description": "The combined intervention will involve all of the interventions in the anxiety and mood risk reduction conditions and thus will not be matched for length."
            }, 
            {
                "arm_group_label": "Repeated Contact Control", 
                "arm_group_type": "No Intervention", 
                "description": "Participants assigned to the repeated contact group will be assigned a \"personal\" study coordinator. The coordinator will contact them at specific intervals during the study. The rationale for these contacts will be provided (e.g., checking in on their status and helping to administer some brief measures). During the three weeks (corresponding to treatment session intervals for those in one of the active treatment conditions), the study coordinator will contact the participant once per week for a brief phone check in where suicide risk will be evaluated. Participants in the control group will also meet with their study coordinator during each of the scheduled follow-up visits."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to test the effectiveness and usability of multiple\n      computer-based treatments for mood and anxiety relevant risk factors. The target of the\n      treatment is related to cognitive stress, which has been shown to be associated with a\n      variety of negative mental health outcomes such as Post-Traumatic Stress Disorder, suicidal\n      ideation, and substance use disorders."
        }, 
        "brief_title": "Depression and Anxiety Reduction Treatment for Suicide", 
        "completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Anxiety", 
            "Depression", 
            "Suicide"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Anxiety Disorders", 
                "Depression", 
                "Depressive Disorder", 
                "Suicide"
            ]
        }, 
        "detailed_description": {
            "textblock": "DARTS is a newly developed computerized treatment targeting specific risk factors associated\n      with suicide, mood, and anxiety symptoms. Eligible individuals will be randomized to one of\n      several conditions. In all conditions, participants will complete various self-report\n      questionnaires and a neurophysiology assessment that involves an EEG. Some participants will\n      also be asked to complete four additional EEG assessments. In addition, all participants\n      will be asked to complete a 1, 3, and 6-month follow-up appointment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  At or above community sample mean on ASI-3\n\n          -  At or above community sample mean on INQ-R\n\n          -  English speakers\n\n          -  18 years of age or older\n\n        Exclusion Criteria:\n\n          -  Significant medical illness\n\n          -  Current substance dependence\n\n          -  Current or past psychotic-spectrum disorders\n\n          -  Uncontrolled bipolar disorder\n\n          -  Serious suicidal intent that warranted immediate treatment"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01941862", 
            "org_study_id": "W81XWH-10-2-0181"
        }, 
        "intervention": {
            "arm_group_label": [
                "Anxiety Risk Reduction", 
                "Mood Risk Reduction", 
                "Combined Risk Reduction"
            ], 
            "intervention_name": "Psychoeducation and Cognitive Bias Modification", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "computerized intervention", 
            "cognitive bias modification", 
            "anxiety", 
            "mood", 
            "perceived burdensomeness", 
            "thwarted belongingness", 
            "suicide", 
            "post-traumatic stress disorder"
        ], 
        "lastchanged_date": "September 25, 2013", 
        "location": {
            "contact": {
                "last_name": "Norman B Schmidt, Ph.D.", 
                "phone": "850-645-1766"
            }, 
            "facility": {
                "address": {
                    "city": "Tallahassee", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32304"
                }, 
                "name": "Florida State University"
            }, 
            "investigator": {
                "last_name": "Norman B Schmidt, Ph.D.", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Development and Evaluation of a Brief, Suicide Prevention Intervention Targeting Anxiety and Mood Vulnerabilities", 
        "other_outcome": {
            "description": "The BSS is a 21-item widely used self-report measure assessing a broad spectrum of behaviors and attitudes related to suicide risk, including suicidal ideation and past suicide attempts. It has demonstrated strong reliability and validity.", 
            "measure": "Beck Suicide Scale (BSS)", 
            "safety_issue": "Yes", 
            "time_frame": "Month 6 follow-up"
        }, 
        "overall_official": {
            "affiliation": "Florida State University", 
            "last_name": "Norman B Schmidt, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The INQ is a 15-item self-report measure of the constructs of thwarted belongingness and perceived burdensomeness as defined by the Interpersonal Theory of Suicide. Van Orden et al. report high internal consistency coefficients for the thwarted belongingness (\u03b1=.85) and perceived burdensomeness subscales (\u03b1=.89). In support of construct validity, both subscales were found to prospectively predict suicidal ideation.", 
            "measure": "Interpersonal Needs Questionnaire (INQ)", 
            "safety_issue": "No", 
            "time_frame": "Month 6 follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01941862"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Florida State University", 
            "investigator_full_name": "Norman Schmidt", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The ASI-3 is an 18-item self-report measure of anxiety sensitivity (AS). This scale was developed to provide a more stable measure of the three most widely recognized AS subfactors (cognitive, social and physical concerns) than the original ASI provides. Each subfactor is represented by six items. The measure has shown good psychometric properties.", 
            "measure": "Anxiety Sensitivity Index-3 (ASI-3)", 
            "safety_issue": "No", 
            "time_frame": "Month 6 follow-up"
        }, 
        "source": "Florida State University", 
        "sponsors": {
            "collaborator": {
                "agency": "Department of Defense", 
                "agency_class": "U.S. Fed"
            }, 
            "lead_sponsor": {
                "agency": "Florida State University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}